Wells Fargo CEO: Interest Rates Need to Normalize
Supreme Court (U.S.)
featured
Among those with an annual household income of less than $30,000, some 30 percent thought the law had been repealed by Congress or the Supreme Court. Congress passed President Barack Obama's health care law in March 2010, and the overhaul has since survived 37 attempts by Republicans in the House of Representatives to eliminate, defund or partly scale it back.
» Read More
More
-
Rejecting an Arizona law, the Supreme Court says states can't require people to prove they are U.S. citizens before using a federal system designed to make registering easier.
-
The Supreme Court says deals between pharmaceutical companies and their generic drug competitors can sometimes be illegal.
-
WASHINGTON, June 17- The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.
-
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would reduce affordability for minorities.
-
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would reduce affordability for minorities.
-
The FTC can challenge deals to keep generic drugs off the market, reports CNBC's Hampton Pearson.
-
WASHINGTON, June 17- The U.S. Supreme Court on Monday agreed to consider whether a New Jersey township's plan to redevelop lower income housing violated the Fair Housing Act because it would negatively impact minorities.
-
The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.
-
NEW YORK, June 13- The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already moved on.
-
A unanimous Supreme Court decision barred patents on naturally occurring DNA, but analysts said the ruling did little harm to biotech companies.
-
CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.
-
*Myriad Genetics shares rise after ruling, then fall. WASHINGTON, June 13- A unanimous U.S. Supreme Court on Thursday prohibited patents on naturally occurring human genes but allowed legal protections on synthetically produced genetic material in a compromise ruling hailed as a partial victory for patients and the biotechnology industry.
-
The Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test. CNBC's Bertha Coombs reports.
-
A check on biotech stocks after the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Seema Mody.
-
In a unanimous decision, the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Hampton Pearson.
-
*Myriad Genetics shares up more than 10 percent after ruling. WASHINGTON, June 13- In a first of its kind ruling on human genes, a unanimous U.S. Supreme Court on Thursday decided that synthetically produced genetic material can be patented but naturally occurring DNA extracted from the human body cannot.
-
WASHINGTON, June 13- The U.S. Supreme Court on Thursday ruled partially for Myriad Genetics Inc on the closely watched issue of whether human genes can be patented, deciding synthetically produced genetic material can be patented but naturally occurring DNA cannot. Myriad's shares jumped more than 8 percent to $36.83 after the ruling was issued.
-
WASHINGTON, June 13- The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes can be patented.
-
WASHINGTON, June 10- The U.S. Supreme Court agreed on Monday to hear British company BG Group Plc's appeal over a $185.3 million arbitration award it won against Argentina that an appeals court later threw out.
-
WASHINGTON, June 10- The U.S. Supreme Court on Monday agreed to hear British company BG Group Plc's appeal over a $185.3 million arbitration award it won against Argentina that an appeals court later threw out.
Most Popular Video
No reason has been given yet for the departure of founder and executive chairman George Zimmer, reports CNBC's Courtney Reagan. Zimmer has long been the face of the company.
Wednesday, 19 Jun 2013 | 10:52 AM ETCNBC's Rick Santelli, explains why he hears 'crickets" when he asks questions about Fed Chairman Bernanke's policies. "Enough is enough," he rants.
Wednesday, 19 Jun 2013 | 11:36 AM ETAre reporters lobbing "softball" questions at the Fed chairman? CNBC's Rick Santelli and the Wall Street Journal's Jon Hilsenrath, debate whether the economy continues to need quantitative easing. I'm trying to inform the public about what the Fed is up to, says Hilsenrath.